--- title: "Pre-market hot trades in US stocks: Lantern Pharma up 7.17% in pre-market; AST SpaceMobile up 3.30% in pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/286414471.md" description: "Lantern Pharma rose 7.17% in pre-market; AST SpaceMobile rose 3.30% in pre-market; Snail rose 184.80% in pre-market; Concorde rose 97.33% in pre-market; Eason Tech rose 80.24% in pre-market" datetime: "2026-05-14T12:12:47.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286414471.md) - [en](https://longbridge.com/en/news/286414471.md) - [zh-HK](https://longbridge.com/zh-HK/news/286414471.md) --- # Pre-market hot trades in US stocks: Lantern Pharma up 7.17% in pre-market; AST SpaceMobile up 3.30% in pre-market **Pre-market Hot Trades in US Stocks** Lantern Pharma is up 7.17% in pre-market trading. Based on recent key news: 1. On May 13, Lantern Pharma announced a registered direct offering agreement of up to $9.25 million with existing holders and a single institutional investor. This news boosted the stock price, reflecting market confidence in the company's financing capabilities. Source: Reuters 2. On May 12, Lantern Pharma plans to release its operational and financial results for the first quarter of 2026 on May 15. The market expects this may positively impact clinical trial and AI platform development, boosting investor sentiment. Source: Business Wire 3. On May 11, Lantern Pharma released related content via Business Wire, emphasizing the company's responsibility in information disclosure. Although this news did not directly affect the stock price, it provided background information for investors. Source: Business Wire The US stock market has recently seen increased volatility, requiring attention to risks. AST SpaceMobile is up 3.30% in pre-market trading. Based on recent key news: 1. On May 12, AST SpaceMobile announced its first-quarter financial report, with revenue of $14.73 million, below analyst expectations, leading to a stock price decline. Analysts had originally expected revenue of $39 million, causing the stock to drop by 11.62%. Source: Barron’s 2. On May 11, AST SpaceMobile's stock rose by 7.04%, as the company reaffirmed its revenue target of $150 million to $200 million for 2026, despite the financial report falling short of expectations, indicating market confidence in its future growth. Source: Reuters 3. On May 13, analysts expressed concerns about AST SpaceMobile's satellite launch plans, which may affect the launch of its commercial services, leading to increased stock price volatility. Source: Investing.com The satellite communication industry faces launch risks, with significant capital inflow. **Top Gainers in Pre-market US Stocks** Snail is up 184.80% in pre-market trading. Based on recent key news: 1. On May 13, Snail announced its first-quarter financial report, with revenue growing 35.7% year-over-year to $27.3 million, and net profit reaching $2.1 million, exceeding market expectations. This strong performance was mainly driven by sales growth from ARK and Bellwright, significantly boosting the stock price. 2. On May 13, Snail announced that multiple AAA and independent games are set to be released in its content pipeline, and plans to expand SaltyTV and launch a stablecoin platform. These plans demonstrate the company's future growth potential, further boosting market confidence On May 13, analysts rated Snail as "Buy" and set a 12-month target price of $3.50, indicating significant upside potential compared to the current stock price. This optimistic analyst expectation also contributed to the rise in stock price. The gaming industry is experiencing strong growth, and market confidence is improving. Concorde rose 97.33% in pre-market trading. Based on recent news, 1. On May 12, Concorde International Group Ltd. released original content through the EDGAR system of the U.S. Securities and Exchange Commission, disclosing the company's latest financial and operational information. This information showed significant progress in multiple areas, enhancing investor confidence and driving a substantial increase in stock price. 2. On May 14, Concorde International Group Ltd. announced that it secured a multi-year contract worth over $10 million in Singapore to provide integrated security solutions. This news further boosted market expectations for the company, leading to a significant rise in stock price. Recent market demand for security solutions has increased, driving up the stock prices of related companies. Eason Tech rose 80.24% in pre-market trading. Based on recent news, 1. On May 12, Eason Technology issued a statement confirming that the company is operating normally and in compliance with regulations. The company stated that there is no significant undisclosed information or undisclosed business developments, and this statement aims to address the unusual market fluctuations. 2. On May 12, Eason Technology announced in Hong Kong that it reaffirms the normal operation of its business in real estate operation management, investment, and digital technology security. 3. On May 12, Eason Technology issued a statement in accordance with NYSE American rules to respond to unusual market fluctuations, confirming that the company is operating normally and in compliance with relevant regulations. The market reacted positively to the company's statement, driving a substantial increase in stock price ### Related Stocks - [LTRN.US](https://longbridge.com/en/quote/LTRN.US.md) - [ASTS.US](https://longbridge.com/en/quote/ASTS.US.md) - [SNAL.US](https://longbridge.com/en/quote/SNAL.US.md) - [YOOV.US](https://longbridge.com/en/quote/YOOV.US.md) - [DXF.US](https://longbridge.com/en/quote/DXF.US.md) ## Related News & Research - [What is one of the best growth stocks to buy with $500 today?](https://longbridge.com/en/news/286478811.md) - [SpaceX sets June 12 IPO at up to $2T valuation](https://longbridge.com/en/news/286847957.md) - [Should you invest $1,000 in AGNC Investment right now?](https://longbridge.com/en/news/286802595.md) - [Lantern Pharma shifts LP-300 Phase 2 HARMONIC trial to single-arm L858R focus](https://longbridge.com/en/news/286903851.md) - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)